Vetoquinol is one of the main international players in animal health for livestock and pets. We’re an independent company, solely focused on innovating, developing, producing, and marketing veterinary drugs and non-medicinal products globally.
In 2023, our organisation registered a sales revenue of €529 million. This was from 24 countries with equal amounts coming from farm animals and pets. it was all thanks to our established network of over 60 partner distributors.
Since our creation in 1933, Vetoquinol has combined innovation and geographical diversification. The strengthening of our product portfolio – and various acquisitions – has ensured growth for our group. Today, Vetoquinol employs more than 2,500 people.
Vetoquinol’s key figures for 2023:
| 2023 turnover: € 529 million Essential* products turnover: € 313 million |
Breakdown of group turnover by activity: Pets 70% Livestock 30% |
* Vetoquinol key products.
